These data indicated that MCP-4 and eotaxin-3 were potential markers for the clinical course of COPD, which could provide guidance for accurate diagnosis and treatment for this disease in future clinical practice. The gene discussed is CCL13; the disease is chronic obstructive pulmonary disease.